Table 2.
Patient demographics and characteristics.
| Characteristic | All patients | Men | Women | p |
|---|---|---|---|---|
| Number of patients | 26 | 17 | 9 | |
| Mean age (year) | 50.6 (22–89) | 54.22 (25–89) | 45.17 (22–68) | 0.89 |
| Mean psoriasis duration (year) | 13.13 (0–41) | 12.33 (0.5–35) | 14.13 (0–41) | 0.87 |
| Mean current joint symptom duration (month) | 26.88(1–192) | 40.3 (1–192) | 24.8 (1–120) | 0.64 |
| Mean interval between the two DECTs (month) | 7.02 (4–12) | 7 (4–12) | 6.35 (4–11) | 0.97 |
| Mean PASI score | 3.78 (0–27.3) | 2.85 (0–10.2) | 5.54 (0–27.3) | 0.67 |
| Fulfilled CASPAR criteria | 26 | 17 | 9 | 0.21 |
| Mean C-reactive protein level (mg/dL) | 1.11 (0.04–6.05) | 0.98 (0.04–5.45) | 1.34 (0.04–6.05) | 0.5 |
| Nail change | 16 | 11 | 5 | 0.69 |
Note.- Numbers in parentheses are ranges. CASPAR = Classification Criteria for Psoriatic Arthritis, PASI = Psoriasis Area Severity Index. To convert milligrams per deciliter to nano moles per liter, multiply by 9.524. *P < 0.05 was considered statistically significant.